Investigation of the production of high quality biogasoil from pre-hydrogenated vegetable oils over Pt/SAPO-11/Al2O3

Author(s):  
J. Hancsók ◽  
M. Krár ◽  
Sz. Magyar ◽  
L. Boda ◽  
A. Holló ◽  
...  
2012 ◽  
Vol 16 (12) ◽  
pp. 2273-2280 ◽  
Author(s):  
Shauna M Downs ◽  
Anne Marie Thow ◽  
Suparna Ghosh-Jerath ◽  
Justin McNab ◽  
K Srinath Reddy ◽  
...  

AbstractObjectiveIndia has proposed legislating an upper limit oftransfat in partially hydrogenated vegetable oils and mandatingtransfat labelling in an effort to reduce intakes. The objective of the present study was to examine the complexities of regulatingtransfat in India by examining the policy processes involved and the perceived implementation challenges.DesignSemi-structured interviews (n18) were conducted with key informants from various sectors. Interviewees were asked about sources oftransfat in the food supply, existing policies that may influencetransfats and perceived challenges related to the proposedtransfat regulation, in addition to questions tailored to their area of expertise. Interview data were organised based on common themes.SettingInterviews were conducted in India.SubjectsInterviewees were key informants from various sectors including agriculture, trade, industry and health.ResultsSeveral themes were identified related to the complexity of regulatingtransfat in India. A lack oftransfat awareness, the large unorganised retail sector, a need for suitable alternative products that are both acceptable to consumers and affordable, and a need to build capacity were crucial factors affecting India's ability to successfully regulatetransfat. The limited number of food inspectors will create an additional challenge in terms of enforcement oftransfat regulation.ConclusionsAlthough India will face challenges in regulatingtransfat, legislating an upper limit oftransfat in partially hydrogenated vegetable oils will likely be the most effective approach to reducing it in the food supply. Ongoing engagement with industry, agriculture, trade and processing sectors will prove essential in terms of product reformulation.


1983 ◽  
Vol 60 (4) ◽  
pp. 811-814 ◽  
Author(s):  
A. M. Nash ◽  
T. L. Mounts ◽  
W. F. Kwolek

2013 ◽  
Vol 41 ◽  
pp. 136-139 ◽  
Author(s):  
Shih-Yuan Chen ◽  
Takehisa Mochizuki ◽  
Yohko Abe ◽  
Makoto Toba ◽  
Yuji Yoshimura

2009 ◽  
Vol 92 (5) ◽  
pp. 1250-1257 ◽  
Author(s):  
Shyam Mohan Teegala ◽  
Walter C Willett ◽  
Dariush Mozaffarian

Abstract Consumption of industrially produced Trans fatty acids (TFA) remains high in many populations, particularly in developing nations where partially hydrogenated vegetable oils are frequently used for home cooking and among individuals in developed countries having high intakes of bakery or processed foods. Well-controlled observational studies and randomized trials indicate that TFA consumption adversely affects multiple risk factors for chronic diseases, including numerous blood lipids and lipoproteins, systemic inflammation, endothelial dysfunction, and possibly insulin resistance, diabetes, and adiposity. Growing evidence for the latter effects is particularly concerning given the worldwide obesity pandemic and high contents of industrially produced TFA in many foods marketed toward children. Consistent evidence from prospective observational studies of habitual TFA consumption and retrospective observational studies using TFA biomarkers indicates that TFA consumption increases risk of clinical coronary heart disease (CHD). Based on the adverse effects of risk factors and consistent relationships with clinical endpoints, the evidence that TFA consumption increases CHD risk is convincing. Some evidence suggests that TFA consumption may also increase other disease outcomes, but further investigation is needed to confirm the presence and magnitude of such effects. More research is also needed to understand how specific TFA isomers of varying chain length and double bond location may affect different biologic pathways of disease. Both individual- and policy-level initiatives to decrease TFA consumption should continue, particularly in population subgroups and in developing nations with high consumption of partially hydrogenated vegetable oils.


Foods ◽  
2020 ◽  
Vol 9 (6) ◽  
pp. 706
Author(s):  
Andrea Zuzarte ◽  
Melody Mui ◽  
Maria Isabel Ordiz ◽  
Jacklyn Weber ◽  
Kelsey Ryan ◽  
...  

Ready-to-use therapeutic food (RUTF) is a shelf-stable, low moisture, energy dense medicinal food composed of peanut butter, vegetable oils, milk powder, a multiple micronutrient premix and sugar. RUTF is used by millions of children annually to treat malnutrition. After mixing, RUTF is a semisolid covered with oil. To produce a homogenous RUTF, hydrogenated vegetable oils are incorporated in small quantities. This study utilized a benchtop methodology to test the effect of RUTF ingredients on oil separation. An acceptable oil separation was <4%. This method compared 15 different vegetable oil stabilizers with respect to oil separation. The dynamic progression of oil separation followed a Michaelis–Menten pattern, reaching a maximum after 60 days when stored at 30 °C. Hydrogenated vegetable oils with triglyceride or 50% monoglycerides reduced the oil separation to acceptable levels. The additive showing the largest reduction in oil separation was used in an industrial trial, where it also performed acceptably. In conclusion, fully hydrogenated soybean and rapeseed oil added as 1.5% controlled oil separation in RUTF.


Sign in / Sign up

Export Citation Format

Share Document